Synthetic Biologics Inc (SYN) Up 27% After Positive Phase 2 Results are Reported
Shares of Synthetic Biologics Inc (NYSEMKT:SYN) are up big today after the company announced positive Phase 2 Clinical Trial data for their Irritable Bowel Syndrome…
Synthetic Biologics Inc – (NYSEMKT:SYN)
